Latest Leverage News

RocketBoots Limited has secured a significant trial contract with one of Mexico's largest retail banks, marking a key step in its international expansion and potential revenue growth.

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

Ovanti Limited has secured a strategic three-year partnership with Shift4 Payments to launch its innovative Buy Now Pay Later services across over 100,000 US merchants, leveraging AI-driven credit models and stablecoin-backed funding.

Xamble Group Limited is accelerating its transformation into Southeast Asia’s premier influencer marketing platform, reporting strong H1 revenue growth and launching a strategic rights issue to fund expansion and technology upgrades.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper® product, marking a significant step in commercialising sustainable mining solutions.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a major step in sustainable mining innovation.

Pharmx Technologies Limited reported a 13% increase in revenue for FY25, driven by expanded supplier-pharmacy connections and Marketplace platform growth, while profit before tax declined due to significant investments in new technology platforms.

Superloop has reported a robust FY25 with a 31% revenue increase and significant market share gains in the nbn broadband sector, alongside a positive net profit after tax.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

COSOL Limited reported a $7.9 million net profit for FY25 on record $116.8 million revenue, driven by strong organic growth and a strategic acquisition. The company signals margin expansion and robust earnings growth ahead, fueled by AI and digital transformation investments.

Superloop Limited has reported a landmark FY25, posting its first positive net profit after tax since its turnaround began, alongside robust revenue growth and a significant expansion in its customer base.